MicroMass

MicroMass is a leading marketing agency focused on applying evidence-based behavior change strategies to create real-world solutions that optimize patient health outcomes. With expertise in human health behavior, MicroMass builds fundamentally different marketing programs that help patients with chronic conditions, cancer, and rare diseases build the confidence and the skills they need to better engage in their care.

View Case Study
  • MicroMass is a medical marketing agency providing the pharmaceutical and medical device industries with strategic, creative and digital services
  • In December 2015, SPS acquired MicroMass, a marketing agency focused on applying evidence-based behavior change strategies to create real-world solutions that optimize patient health outcomes
  • Substantial expertise and holistic offering of human health behavior, patient engagement and support, and professional advocacy
  • Focus on a strong core of therapeutic areas, including respiratory and rare disease, oncology, infectious diseases, and ophthalmology
  • Periscope sourced the investment and controlled a majority of the Board of Directors; Steve Jarmel (Partner) served as Chairman
  • Pharmaceutical companies are employing outsourced service models to reduce costs
  • Pharmaceutical is conforming to the evolving needs of the digitally inclined constituents as well as more-involved consumers/patients
  • Direct-to-physician marketing model is becoming obsolete creating high demand for targeted communication and marketing strategies
  • Digital has become the preferred communication channel for physicians
  • Built out the Company’s sales organization
  • Enhanced business development initiatives with sales best practices
  • Built out a digital strategy capability to expand service offerings to current customer base
  • Entered new or expanded further into therapeutic areas with strong growth trends such as rare diseases, oncology, and women’s health
  • Instituted KPI’s, financial dashboards, budget process and cash flow management
  • After reviewing six other add-on opportunities, Periscope sourced MicroMass Communications through proprietary transaction
  • Merger doubled the size of the business while accelerating exit timing expectations
  • Sold to UDG Healthcare plc (LON: UDG), in September 2017
Back to portfolio